2 Einträge gefunden

1. Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial

   1. Warren, R B
   2. Lebwohl, M
   3. Sofen, H
   4. Piguet, V
   5. Augustin, M
   6. Brock, F
   7. C Arendt,

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate-to-severe psoriasis: a pooled analysis of two randomized controlled trials

   1. Blauvelt, A
   2. Sofen, H
   3. Papp, K
   4. Gooderham, M
   5. Tyring, S
   6. Zhao, Y
   7. Lowry, S

   2019 - Forschungsinformationssystem des UKE